Improved Host Defense against Pneumococcal Pneumonia in Platelet-Activating Factor Receptor-Deficient Mice

77Citations
Citations of this article
44Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Platelet-activating factor (PAF) is a phospholipid with proinflammatory properties that binds to a specific receptor (PAF receptor [PAFR]) that is expressed on many different cell types. PAFR is able to bind phosphorylcholine, which is present in both PAF and the pneumococcal cell wall. Activation of respiratory epithelial cells in vitro results in up-regulation of PAFR, which, in turn, facilitates invasion of Streptococcus pneumoniae. To determine the role of PAFR in host defense against pneumococcal pneumonia, PAFR-deficient (PAFR-/-) and wild-type (wt) mice were inoculated intranasally with S. pneumoniae. PAFR-/- mice were relatively resistant to pneumococcal pneumonia, as indicated by delayed and reduced mortality, diminished outgrowth of pneumococci in lungs, and reduced dissemination of the infection (all P

Cite

CITATION STYLE

APA

Rijneveld, A. W., Weijer, S., Florquin, S., Speelman, P., Shimizu, T., Ishii, S., & Van Der Poll, T. (2004). Improved Host Defense against Pneumococcal Pneumonia in Platelet-Activating Factor Receptor-Deficient Mice. Journal of Infectious Diseases, 189(4), 711–716. https://doi.org/10.1086/381392

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free